NCT02282215: Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia |
|
|
| Completed | 2 | 163 | US | CLT-008, human allogeneic myeloid progenitor cells (hMPC), romyelocel-L, G-CSF, Neupogen (filgrastim), granulocyte colony-stimulating factor, Zarxio, Granix (tbo-filgrastim) | Cellerant Therapeutics, Department of Health and Human Services | Acute Myeloid Leukemia, Neutropenia, Infection | 09/17 | 09/17 | | |
NCT01297543: Safety Study of Human Myeloid Progenitor Cells (CLT-008) After Chemotherapy for Leukemia |
|
|
| Completed | 1/2 | 45 | US | human myeloid progenitor cells, CLT-008, hMPC, G-CSF, filgrastim, granulocyte colony stimulating factor | Cellerant Therapeutics, Department of Health and Human Services | Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Myelodysplasia | 11/14 | 01/15 | | |
